FXYD4 Activators
FXYD4 activators include a range of chemicals that indirectly influence the activity of FXYD4 through their modulation of Na+/K+-ATPase and associated signaling pathways. These activators operate through various mechanisms, impacting the signaling pathways and cellular processes associated with FXYD4, a key modulator of Na+/K+-ATPase. Compounds like Ouabain and Digoxin, which are known inhibitors of Na+/K+-ATPase, can indirectly affect FXYD4 by altering ion homeostasis and the intracellular signaling environment. This modulation of Na+/K+-ATPase activity provides a pathway through which FXYD4's function can be influenced.
Furthermore, molecules such as Epidermal Growth Factor (EGF), Forskolin, and various hormones like Dopamine, Adrenaline, Insulin, and Angiotensin II demonstrate the ability to influence Na+/K+-ATPase activity, thereby indirectly affecting FXYD4. These compounds act through different receptors and signaling cascades to modulate the activity of Na+/K+-ATPase. For example, EGF activates pathways influencing ion transport, Forskolin increases intracellular cAMP impacting enzyme activity, and hormones like Adrenaline and Insulin modulate Na+/K+-ATPase through adrenergic and insulin signaling, respectively.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP, which can modulate Na+/K+-ATPase activity and potentially influence FXYD4. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine, through its receptors, can influence Na+/K+-ATPase activity, indirectly affecting FXYD4 modulation of the enzyme. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $40.00 $102.00 $197.00 $1739.00 $16325.00 | ||
Adrenaline, acting through adrenergic receptors, can modulate Na+/K+-ATPase activity, potentially influencing FXYD4. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
Insulin can modulate Na+/K+-ATPase activity through various signaling pathways, potentially impacting FXYD4 activity. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $50.00 $75.00 $260.00 $505.00 | 3 | |
Angiotensin II, through its receptor, can influence Na+/K+-ATPase activity, thereby indirectly affecting FXYD4. | ||||||
Aldosterone | 52-39-1 | sc-210774 sc-210774A sc-210774B sc-210774C sc-210774D sc-210774E | 2 mg 5 mg 10 mg 50 mg 100 mg 250 mg | $254.00 $209.00 $311.00 $1520.00 $3014.00 $7487.00 | 1 | |
Aldosterone modulates Na+/K+-ATPase activity through mineralocorticoid receptors, potentially influencing FXYD4. | ||||||
L-Noradrenaline | 51-41-2 | sc-357366 sc-357366A | 1 g 5 g | $320.00 $475.00 | 3 | |
noradrenaline can modulate Na+/K+-ATPase activity, indirectly affecting FXYD4. | ||||||